NCT04443920View on ClinicalTrials.gov

Tranexamic Acid for Total Knee Arthroscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

October 7, 2020

Study Completion Date

January 8, 2021

Conditions
Blood Loss, Surgical
Interventions
DRUG

Tranexamic acid (TXA)

Randomly assigned \[1:1 ratio\] using a computer generated table of random numbers to 1 of the 2 intervention groups

DRUG

Placebo Normal Saline (NS)

Randomly assigned \[1:1 ratio\] using a computer generated table of random numbers to 1 of the 2 intervention groups

Trial Locations (1)

02903

Miriam Hospital, Providence

All Listed Sponsors
lead

The Miriam Hospital

OTHER

NCT04443920 - Tranexamic Acid for Total Knee Arthroscopy | Biotech Hunter | Biotech Hunter